Vienna, Austria

Wolfgang R Sperr

This inventor holds 11 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Phadia Ab, Pharmacia Diagnostics Ab, Pharmacia Ab. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang R Sperr. Retrieved from https://idiyas.com/inventor/wolfgang-r-sperr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 63.6



Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • A-1190, Wein, AT (2007)
  • Vienna, AT (2003 - 2013)

Company Filing History:


Years Active: 2003-2013

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Wolfgang R. Sperr: Innovator in Allergy Treatment

Introduction

Wolfgang R. Sperr is a prominent inventor based in Vienna, Austria, recognized for his significant contributions to the field of allergy research. With a total of 11 patents to his name, Dr. Sperr has developed groundbreaking methods aimed at treating allergies and asthma, materially impacting the lives of individuals suffering from these conditions.

Latest Patents

Among his latest patents are innovative therapeutic approaches designed to mitigate allergic responses. One noteworthy patent focuses on non-anaphylactic forms of the grass pollen Phl p 6 allergen. This invention outlines methods for desensitizing mammals suffering from IgE-mediated allergies. It involves administering an immunogenic and hypoallergenic composition containing a Phl p 6 molecule, which is strategically truncated at either the N-terminal or C-terminal to eliminate IgE binding capacity. This inventive approach aims to create a comprehensive span of Phl p 6 while ensuring safety and efficacy through a pharmaceutical carrier.

Another significant patent by Dr. Sperr presents a novel drug candidate with potential for universal therapy for allergy and asthma. This invention details a Fab (antibody fragment) that offers promising characteristics for treating these ailments.

Career Highlights

Dr. Sperr has garnered extensive experience through his longstanding career, notably working with leading companies in the biotech industry. He has contributed to organizations such as Phadia AB and Pharmacia Diagnostics AB, where he applied his expertise in immunology and therapeutic innovation.

Collaborations

Throughout his career, Dr. Sperr has collaborated with distinguished professionals in the field. His noteworthy coworkers include Peter Valent and Rudolf Valenta, who have also significantly contributed to advancements in allergy research.

Conclusion

Wolfgang R. Sperr continues to be an influential figure in the realm of allergy treatment through his innovative inventions and collaborative efforts. With his dedication to improving the lives of those suffering from allergies and asthma, he exemplifies the spirit of innovation that drives advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…